Citi raised the firm’s price target on IFF to $116 from $108 and keeps a Buy rating on the shares. The firm updated estimates for the remainder of its chemicals coverage ahead of Q2 earnings. It sees the most weakness in lithium for Q2 and the balance of the year, with continued price declines and few signs of supply cuts. Citi maintains its constructive end-market view on electronics and flavors and fragrances.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IFF:
- IFF price target raised to $100 from $95 at UBS
- IFF price target raised to $103 from $100 at Morgan Stanley
- Uber, Birkenstock among additions to Deutsche Bank ‘Fresh Money List’ for Q3
- ‘We Stay Bullish’: Oppenheimer Suggests 2 Stocks to Buy Amid Market’s Record Highs
- IFF initiated with an Outperform at Oppenheimer